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Background
Malignant hyperthermia (MH) is characterized by an
adverse reaction to volatile anesthetic, and/or succinyl-
choline. Typically, following an adverse anesthetic reac-
tion or positive family history, patients will undergo
caffeine-halothane contracture (CHCT) and/ or genetic
testing. However, sometimes patients with no individual
or family history of anesthetic reaction are referred for
MH testing due to a variety of reasons. The objective of
our study was to investigate reasons for referrals in non-
anesthetic cases, and assess their phenotype.
Materials and methods
Following institutional research ethics board approval,
all the CHCT-tested probands at our MH center were
identified. Patients with anesthetic reactions were
excluded. Reasons for referrals, baseline CK, genetics
results, histopathology were analyzed and compared
between patients with positive and negative CHCT
results. Response to dantrolene among patients with
positive CHCT was also assessed. Wilcoxon rank sums
test, and fisher’s exact test were used for numerical, and
categorical parameters, respectively.
Results
Between 1992-2012, 152 probands with no anesthetic
reaction were identified. Of these, 104 (68.4%) had posi-
tive CHCT. Reasons for referrals included unexplained
high creatine kinase-CK (50.6%), post-viral chronic fati-
gue (41.4%), post-exercise rhabdomyolysis (7.9%), and
heat stroke (0.6%).
Fifty-nine patients with high CK (76.6%), and 36
patients with post-viral chronic fatigue (57.1%) had posi-
tive CHCT based on the standardized North American
CHCT test protocol. The viral illness included influenza,
Epstein-Barr, and cytomegalovirus. The fatigue was
defined as muscle pain, weakness, and cramps, interfer-
ing with functional ability, lasted more than three
months after the onset of viral illness.
Thirty-eight (36.5%) patients with positive CHCT had
abnormal histomorphology, which included central cores,
and multi-minicores. Three patients carried causative
mutations in Ryanodine receptor-I (RYR-I); of these,
2 were referred for unexplained high CK, and 1 was
referred for exercise-induced rhabdomyolysis. Forty
patients with positive CHCT (38.4%) were given oral dan-
trolene, in which 30 (75.0%) responded with improvement
of musculoskeletal symptoms, and reduction in CK.
Conclusions
MH susceptibility as confirmed by the caffeine halothane
contracture test may predispose patients to a variety of
non anesthetic induced muscle abnormalities. The results
support the contention that MH maybe more than an
anesthetic disorder but should be interpreted in the con-
text of the limitations of the sensitivity of the CHCT.
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